About Neomend
Neomend is a company based in Irvine (United States) founded in 1999 was acquired by CR Bard in October 2012.. Neomend has raised $38.83 million across 3 funding rounds from investors including Blackstone, CR Bard and Sanderling Ventures. Neomend operates in a competitive market with competitors including Cohera Medical, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neomend Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.83 M (USD)
in 3 rounds
-
Latest Funding Round
$33.12 M (USD), Series D
Feb 04, 2010
-
Investors
Blackstone
& 5 more
-
Employee Count
Employee Count
-
Acquired by
CR Bard
(Oct 23, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neomend
Neomend has successfully raised a total of $38.83M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $33.12 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $33.1M
-
First Round
First Round
(14 May 2009)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2010 | Amount | Series D - Neomend | Valuation | Sanderling Ventures , Prospect Venture Partners |
|
| Sep, 2009 | Amount | Unspecified - Neomend | Valuation |
investors |
|
| May, 2009 | Amount | Unspecified - Neomend | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neomend
Neomend has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Blackstone, CR Bard and Sanderling Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and healthtech firms.
|
Founded Year | Domain | Location | |
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neomend
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neomend
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neomend Comparisons
Competitors of Neomend
Neomend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cohera Medical, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| domain | founded_year | HQ Location |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic sealants for surgeries
|
|
| domain | founded_year | HQ Location |
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Biomaterials for surgery and wound repair are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neomend
Frequently Asked Questions about Neomend
When was Neomend founded?
Neomend was founded in 1999 and raised its 1st funding round 10 years after it was founded.
Where is Neomend located?
Neomend is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Is Neomend a funded company?
Neomend is a funded company, having raised a total of $38.83M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $2.7M, raised on May 14, 2009.
What does Neomend do?
Provider of air leak sealant for thoracic surgery. By using the proprietary Hydrogel technology platform the company has developed advanced wound care products for a variety of applications, including wound healing, prevention of post-surgical adhesions, and site-specific, sustained drug delivery. The lead product is Progel Pleural Air Leak Sealant, for lung surgery.
Who are the top competitors of Neomend?
Neomend's top competitors include OptMed, GATT Technologies BV and Sealonix.
Who are Neomend's investors?
Neomend has 6 investors. Key investors include Blackstone, CR Bard, Sanderling Ventures, Prospect Venture Partners, and Vivo Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.